Immunosuppression induced by cancer cells and CD4+ immunosuppressive cells (e.g. Foxp3+ T regulatory cells) limits the anti-tumor effect of effector CD8+ T cells [1–3]. The gene discussed is FOXP3; the disease is neoplasm.